What is another term for inhaled anticholinergics?

Inhaled anticholinergics are commonly referred to as Long-Acting Muscarinic Antagonists (LAMAs). This terminology reflects their pharmacological action, where they act as antagonists at muscarinic receptors in the lungs, leading to bronchodilation. By blocking the action of acetylcholine, these medications help to relax the airway muscles and improve airflow, making them particularly useful in the management of conditions such as chronic obstructive pulmonary disease (COPD) and asthma.

The distinction of "long-acting" is important because these agents are designed to provide sustained bronchodilation over an extended period, which can enhance patient compliance and overall effectiveness in managing respiratory symptoms compared to shorter-acting agents. This classification is critical for healthcare providers when considering treatment plans for patients with obstructive airway diseases.